[
    [
        {
            "time": "",
            "original_text": "此外，，在政策、人才回流等多重因素推动下，我国创新药研发火热，这也进一步促进了我国CXO行业发展。",
            "features": {
                "keywords": [
                    "政策",
                    "人才回流",
                    "创新药研发",
                    "CXO行业"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "此外，，在政策、人才回流等多重因素推动下，我国创新药研发火热，这也进一步促进了我国CXO行业发展。",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "黄金赛道CXO|从实验室化学到CXO“全家桶”，康龙化成要向药明康德看齐？",
            "features": {
                "keywords": [
                    "CXO",
                    "康龙化成",
                    "药明康德"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "CXO"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "黄金赛道CXO|从实验室化学到CXO“全家桶”，康龙化成要向药明康德看齐？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周观点：中报业绩陆续披露 关注基本面变动",
            "features": {
                "keywords": [
                    "医药生物",
                    "中报业绩",
                    "基本面变动"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业周观点：中报业绩陆续披露 关注基本面变动",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【行情】CRO概念持续走弱，皓元医药跌超5%，睿智医药、康龙化成、昭衍新药跟跌",
            "features": {
                "keywords": [
                    "CRO概念",
                    "皓元医药",
                    "睿智医药",
                    "康龙化成",
                    "昭衍新药"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "CRO"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【行情】CRO概念持续走弱，皓元医药跌超5%，睿智医药、康龙化成、昭衍新药跟跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(300759)：H1收入持续提速 运营效率提升拉动业绩大幅增长",
            "features": {
                "keywords": [
                    "康龙化成",
                    "H1收入",
                    "运营效率",
                    "业绩增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(300759)：H1收入持续提速 运营效率提升拉动业绩大幅增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "【医药-马帅】康龙化成：一体化服务平台驱动各项业务快速发展，2021H1业绩增长符合预期",
            "features": {
                "keywords": [
                    "康龙化成",
                    "一体化服务平台",
                    "业务发展",
                    "2021H1业绩"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药-马帅】康龙化成：一体化服务平台驱动各项业务快速发展，2021H1业绩增长符合预期",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 5,
                "Source_Recency": 10
            }
        }
    ]
]